Miss Dana Gourevich holds a BSc in Pharmaceutical Chemistry from Bar Ilan University, Israel. Dana was seconded to Institute for Medical Science and Technology from CapsuTech LTD as a part of the Nanoporation project. The Nanoporation project aims to increase the local concentration of the drug at targeted region by the use of Magnetic Resonance guided Focused Ultrasound (MRgFUS), while reducing side effects by the use of novel drug nano vehicles. In addition to IMSaT, the project combines the effort of two industrial companies CapsuTech, Nazareth Israel and InSightec, Haifa, Israel.

CapsuTech is an SME company focused on research and development of semi-natural, peptide-based polymers for drug targeting and encapsulation of various chemical and biological agents. Use of various combinations of modified amino-acid building-blocks allows the synthesis of high-diversity population of polymers and thus enabling the formulation of large spectrum of molecules to meet specific and various needs including targeting, site-specific release and controlled release, as well as protection from pH, enzyme proteolysis, oxidation, and other damaging factors.

Dana, being a project's ESR, is currently performing cellular drug uptake under MRgFUS application. As part of the project, Dana is also a full time PhD student in the University of Dundee.

• Gourevich D and et al. Ultrasound activated nano-encapsulated targeted drug delivery and tumour cell poration. (2011) 47^th Oholo conference in the "Advances in Experimental Medicine and Biology" (AEMB) (submitted)